DICE Therapeutics
Vivy Alimin Buntaran has a comprehensive work experience in the field of clinical data management. Vivy Alimin is currently employed as the Director of Clinical Data Management at DICE Therapeutics, a position they have held since September 2022. Prior to this, they worked as the Associate Director of Clinical Data Management at the Parker Institute for Cancer Immunotherapy from June 2021 to September 2022.
Before joining the Parker Institute, Vivy served as the Supervisor of Data Management at Seattle Children's Therapeutics at Seattle Children's Hospital from March 2020 to May 2021. Vivy Alimin played a crucial role in overseeing data management operations.
Vivy also has a strong background in data infrastructure and project management. Vivy Alimin spent a significant part of their career at Axio Research, where they held several positions. From November 2016 to March 2020, they served as the Manager of Data Infrastructure, leading the development and maintenance of data systems. Previously, they worked as a Clinical Data Project Manager from June 2013 to November 2016 and as a Senior Data Coordinator from June 2009 to May 2013. Vivy Alimin began their tenure at Axio Research as a Data Coordinator in May 2007.
Before joining Axio Research, Vivy started their career as a Research Assistant at Biopath, Inc. from October 1996 to December 2001.
Overall, Vivy Alimin Buntaran has amassed considerable experience and expertise in clinical data management, data infrastructure management, and project management throughout their career.
Vivy Alimin Buntaran holds a Master of Science degree in Clinical Research Administration from Walden University. Prior to their master's degree, they completed their Bachelor of Science in Chemical Engineering at the University of Washington. In addition to their academic qualifications, Vivy has obtained several certifications related to their field. Vivy Alimin is an eClinicalOS Certified Designer, certified by Merge Healthcare, an IBM Company, which they attained in February 2016. Vivy Alimin'sother certifications include being a Medidata Rave Certified Study Builder, certified by Medidata Solutions in September 2014, and a Certified Clinical Data Manager (CCDM) certified by the Society for Clinical Data Management in July 2009.
This person is not in any offices
DICE Therapeutics
At DICE Therapeutics, we design and develop innovative therapies in immunology for patients with debilitating disease. Seeking to create a future where convenient oral medicines with biologic-like efficacy are available to patients with serious medical conditions, we are developing oral alternatives to medicines currently limited to injectable forms. We believe that such pills will be widely appreciated by patients and doctors alike, as they provide a lower bar to entry than biologics, and as oral medicines can easily be co-formulated with other efficacious drugs. The combination of our core technology with additional, unique biophysical insights has enabled DICE to target protein-protein interactions with small molecules. In doing so, DICE has cracked open a previously intractable set of clinically validated therapeutic targets, including Interleukin-17 (IL-17). Our lead program – an orally bioavailable IL-17 antagonist for the treatment of psoriasis – is currently progressing through IND-enabling studies. In parallel, we continue to advance both partnered and internal pipeline drug discovery programs, providing a robust pre-clinical pipeline.